Correction to: Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
| Autor: | Soo-Jin Kim, Jin-Seok Lee, Chang-Gue Son, Doyoung Kim, Samuel-Young Park |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent medicine.medical_treatment Psychological intervention MEDLINE lcsh:Medicine General Biochemistry Genetics and Molecular Biology law.invention Randomized controlled trial law Statistical significance Acupuncture medicine Chronic fatigue syndrome Humans Randomized Controlled Trials as Topic Rehabilitation Fatigue Syndrome Chronic Cognitive Behavioral Therapy business.industry lcsh:R Correction General Medicine medicine.disease Checklist Exercise Therapy Physical therapy Female business |
| Zdroj: | Journal of Translational Medicine Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020) |
| ISSN: | 1479-5876 |
| Popis: | Although medical requirements are urgent, no effective intervention has been proven for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). To facilitate the development of new therapeutics, we systematically reviewed the randomized controlled trials (RCTs) for CFS/ME to date.RCTs targeting CFS/ME were surveyed using two electronic databases, PubMed and the Cochrane library, through April 2019. We included only RCTs that targeted fatigue-related symptoms, and we analyzed the data in terms of the characteristics of the participants, case definitions, primary measurements, and interventions with overall outcomes.Among 513 potentially relevant articles, 55 RCTs met our inclusion criteria; these included 25 RCTs of 22 different pharmacological interventions, 28 RCTs of 18 non-pharmacological interventions and 2 RCTs of combined interventions. These studies accounted for a total of 6316 participants (1568 males and 4748 females, 5859 adults and 457 adolescents). CDC 1994 (Fukuda) criteria were mostly used for case definitions (42 RCTs, 76.4%), and the primary measurement tools included the Checklist Individual Strength (CIS, 36.4%) and the 36-item Short Form health survey (SF-36, 30.9%). Eight interventions showed statistical significance: 3 pharmacological (Staphypan Berna, Poly(I):poly(CThis systematic review integrates the comprehensive features of previous RCTs for CFS/ME and reflects on their limitations and perspectives in the process of developing new interventions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink